These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 29992836)
1. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents. Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
4. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents. Elsaman T; Mohamed MS; Mohamed MA Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910 [TBL] [Abstract][Full Text] [Related]
5. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis. Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents. Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents. Wang A; Yang Y; Jun Y; Wang B; Lv K; Liu M; Guo H; Lu Y Bioorg Med Chem; 2018 May; 26(8):2073-2084. PubMed ID: 29551372 [TBL] [Abstract][Full Text] [Related]
9. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent. Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207 [TBL] [Abstract][Full Text] [Related]
10. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles. Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766 [TBL] [Abstract][Full Text] [Related]
11. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against Komarova K; Vinogradova L; Lukin A; Zhuravlev M; Deniskin D; Chudinov M; Gureev M; Dogonadze M; Zabolotnykh N; Vinogradova T; Lavrova A; Yablonskiy P Molecules; 2024 Jun; 29(13):. PubMed ID: 38999023 [TBL] [Abstract][Full Text] [Related]